Article

Efficacy Trajectory and Hematologic Safety of Oral JAK Inhibitors in Elderly Patients with Moderate-to-Severe Atopic Dermatitis: A Prospective Real-World Study

2026-06-17

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Elderly patients with moderate-to-severe atopic dermatitis (AD) often have multiple comorbidities and immunosenescence, raising concerns regarding the efficacy and safety of systemic therapies. Real-world evidence on oral Janus kinase (JAK) inhibitors in this population remains limited. <bold>Methods:</bold> In this prospective real-world cohort, 90 elderly...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cb4271ff-f47d-59df-bd21-2fd005d0f593
DOI: 10.21203/rs.3.rs-10049334/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Efficacy Trajectory and Hematologic Safety of Oral JAK Inhibitors in Elderly Patients with Moderate-to-Severe Atopic Dermatitis: A Prospective Real-World StudyDOI 10.21203/rs.3.rs-10049334/v1Read

Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Pivotal Phase 3, Randomised, Double-Blind, Placebo-Controlled Study (AD Up)Semantic proximity Read

Navigating the atopic dermatitis toolbox: Challenging scenarios and shared decision-making.Semantic proximity Read

Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularisSemantic proximity Read

Current updates in the epidemiology and comorbidities of atopic dermatitis.Semantic proximity Read

Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) Registry.Semantic proximity Read

Adult-Onset Atopic Dermatitis: Presentations and Progress.Semantic proximity Read

Upadacitinib: Mechanism of action, clinical, and translational scienceSemantic proximity Read

Atopic Dermatitis Beyond the Skin Barrier: Precision Medicine Approaches to Immunological Profiling and Therapeutic InnovationSemantic proximity Read

Immunological Differences in Atopic Dermatitis Across Age Groups: Insights from Single-Cell Multi-OmicsSemantic proximity Read

The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment.Semantic proximity Read

Impact of dupilumab and upadacitinib treatment on epigenetic and transcriptomic alterations in skin-homing T cells of atopic dermatitis patientsSemantic proximity Read

Association of demographic characteristics, aggravating factors, comorbidities and treatments with atopic dermatitis severitySemantic proximity Read